Adisturbed methylation has been proposedasamechanism via which homocysteine is associated with diseaseslikevascular disease,n eural tube defects and mental disorders. Catechol-O-methyltransferase (COMT) is involved in the S-adenosylmethionine-dependent methylation of catecholamines and catecholestrogens and in this waycontributes to homocysteine synthesis.C OMT dysfunctionh as been related to schizophrenia and breast cancer. We hypothesized that COMT dysfunction by virtue of functional genetic polymorphisms maya ffectp lasma total homocysteine (tHcy).Our primaryobjectivewas to study thea ssociationb etween common COMT polymorphisms and tHcy.Secondly, we evaluatedthese polymorphisms as ariskfactor forr ecurrent venous thrombosis.Weo btained genotype datafromfour polymorphisms in theCOMT gene (rs2097603,
Introduction
Adisturbedhomocysteine metabolism has beenassociatedwith diseases of the vascularsystem, both of arterial and venous origin (1) (2) (3) .Inaddition, high plasma total homocysteine (tHcy) increases the risk of spina bifida, and mental disorderslikeschizophrenia and Alzheimer'sdisease (4) (5) (6) . The mechanism of how homocysteine is related to disease is still obscure (7) , butthere are strongi ndications that ad isturbedt ransmethylation may partlyexplain this association (8) (9) (10) (11) .Several studiesshowthat plasma total homocysteine levels (tHcy) correlatewellwith plasma S-adenosylhomocysteine (AdoHcy) (12,1 3), as trong inhibitoro fS -adenosylmethionine (AdoMet)-dependent methyl-ation. Giventhe importanceofmethylation of nucleic acids,proteins, lipids (8, 10, 14, 15) , butalso hormonesand neurotransmitters (16, 17) , it seems plausible that the inhibition or dysfunction of specificmethyltransferases affect critical processesand henceconferahigherrisk of disease.
Thee nzyme Catechol-O-methyltransferase (COMT,E .C. 2.1.1.6) is one of the methyltransferasesthatishighly susceptible to inhibitionbyAdoHcy (18) . COMT represents amajorpathway in the degradation of catecholamine neurotransmitters, likedopamine and (nor)adrenaline, and catecholestrogens.Hence, COMT dysfunction hasbeen implicated in complexdiseaseslikeschizophrenia,Parkinson'sdisease andbreastcancer (17, (19) (20) (21) .
COMT enzyme exists as amembrane-bound(MB) and soluble (S) isoform,the expression of whichisregulated by twodifferent promoters. Acommon 324G>Apolymorphism (rs4680) in the COMT gene,resulting in avaline-to-methioninesubstitution at position 108 (S-isoform) and 158 (MB-isoform), has been studiede xtensively for its effect on enzyme activity and expression, although the data is non-consistent (22, 23) .
The metabolic pathwaysofCOMT and homocysteine are interconnected as the O-methylation of catecholaminesand catecholestrogens catalyzedbyCOMT produces homocysteine ( Fig.  1 ). Therefore, functional variantswithin the COMT gene mayinfluence tHcylevelsand possibly reflect disturbed transmethylation capacity implicated in COMT-related diseases. This is illustrated by the fact thatw ed id find an interaction between MTHFR and COMT in relation to schizophreniarisk (25) .
Theprimary objective of our study wastoinvestigatethe effect of geneticv ariations within the COMT gene on tHcyb y means of haplotypea nalysis. Considering the controversy whether the 324G>Av ariant is causally related to decreased enzyme activity or expression, we includedthreeothervariants (rs2097603) [22] , rs4633 and rs174699) in or directlyadjacent to the COMT gene in our analyses. Secondlyw ee valuatedthesepolymorphismsasarisk factor forrecurrentvenous thrombosis.
Materialand methods

Subjects usedinthe presentstudy
The study group wasr ecruitedv ia ag eneral practicei nT he Hague, the Netherlands, and has beendescribed in moredetail elsewhere (25) .R ecurrentv enous thrombosis cases were selected fromt he fileso ft he anticoagulant clinic in Leyenburg Hospital in The Hague, The Netherlands,a nd control subjects were recruitedvia ageneral practice; pregnancywas the onlyexclusion criterion. Fort he current association study,D NA was availablef rom 438c ontrol subjects and 169 recurrent venous thrombosis patients. With these numbers we had powerof50to 78% to detect ad ifference of 10 to 15% in tHcy( twos ided α = 0.05). The powertodetect an effect of COMT genotypeonvenous thrombosis was54%.
Biochemicalparameters
Bloodsamples were drawn after an overnightfastfrom the ante-cubitalveinin5mlV acutainer tubesand 4.5 ml EDTAvacuum glass tubes for determination of totalplasma homocysteine and forDNA extraction. EDTA samples forhomocysteine measurement were placed on iceimmediately and centrifuged at 3,500g for 5minutes(min) with minimaldelay.The plasma wasseparated and thenstored at -20ºC. Totalplasma homocysteine concentrations were measured by an automated high-performance liquid chromatographym ethodw ith reverse phase separation and fluorescent detection (Gilson 232-401s amplep rocessor, Spectra Physics8800 solvent delivery systemand LC 304 fluorometer)(26). DNAextraction wasperformed as described previously (27) , and the DNAwas storedat4ºC.
Genotype analysis
We genotypedf our singlen ucleotide polymorphisms( SNPs) distributedoverthe gene of interest: rs2097603, rs4633, rs4680 (sometimes referred to as rs165688)a nd rs174699. The SNPs were chosen based on frequency, functionality and location within the gene.All fourcreated or abolishedanenzyme restriction sitea llowingas imple screening based on restriction-fragment length polymorphism( RFLP) analysis. Screening conditions were similarinall analyses.For details see Table1.PCR conditions:4m in at 94°C, 35 cycles of 94°C/60 seconds (s), 52-60°C/60 s, and 72°C/30 s, and afinalextension of 7min at 72°C. Each PCR reaction mixturecontained 50 ng of both forward and reverse primer( Biolegio BV,T he Netherlands), 200 µ MdNTPs, 10 mM Tris-HCl buffer (pH8.2), 50 mM KCl, 2.0-4.0 mM MgCl 2 ,0.5 UofrecombinantTaq polymerase, 5% DMSO (Invitrogen, TheNetherlands)and 75 ng DNA. The resulting PCRproduct wasdigestedbyatleast10units of restriction enzyme (all from NewEngland Biolabs, Inc.) and incubated for 3hours or overnightat37°C.The digests were analyzed by gel electrophoresis on a3 %o r4 %a garoseg el,s tainedw ith ethidiumbromide and visualizedb yU V. In all PCR amplifications and restriction analyses,D NA samples from whicht he genotype had beeni dentified by sequencea nalysis serveda s positivecontrols. From 401 population-based controls, genotype data wasavailablefor all four SNP's (althoughthe total number of genotypedindividuals were differentfor each polymorphism).
Figure1:Simplifiedrepresentation of homocysteine metabolism and the location of Catechol-o-methyltransferase (COMT) enzyme within this metabolism.
Abbreviations: Met,methionine; AdoMet, S-adenosylmethionine; AdoHcy,S-adenosylhomocysteine;Hcy,homocysteine; MS,Methionine Synthase; THF,tetrahydrofolate; MTHFR, methylenetetrahydrofolatereductase.
In addition, data of four other reported variants( i.e.r s6267 [Ala22Ser] [28] , rs740602, rs13306281 and rs3218737) wasobtained from 150 subjects from the same population by means of sequenceanalysis using the ABI Prism 3130XL automatedsequencer according to the instructions of the manufacturer (Applied Biosystems, The Netherlands). However, three of themappearednon-polymorphic, while rs740602w as foundonlyonce in the heterozygous state (minor allele frequencyof<0.01) and all were excluded fromf urther analysis. Fort he case-control study,genotype data (rs4680) from 169cases with ahistoryof venous thrombosis wasobtained.
Statisticalanalyses
Haploview(29) wasusedtoevaluate linkage disequilibrium(LD) andcorrelations between theSNPs. Haplotypeassociationanalysesfor homocysteine levels were performedusing Whap.Whap (http://pngu.mgh.harvard.edu/purcell//whap) takes the ambiguity in individual haplotypeestimations into accountbyapplying aw eightedlikelihoodapproach.Prior to the haplotype analyses, the logtransformedHcy values were standardized.Weused permutation testing as implemented in the Whap programtocorrect for multiple testing in all analyses.H aplotypesw ith af re-quencyoflessthan2%wereexcludedfrom the analysis. Singlelocus genotypee ffects on (log-transformed) metabolitesw ere evaluated by linear regression analysis (SPSS 12.0). In the haplo- 
Results
Populationcharateristicsand genotyping
Baselinec haracteristics of the study populations ares hown in Table1. Fordetails about these SNPs regarding location, function and validation method,s ee Table2 .T he four COMT SNPs under study were all in Hardy-Weinberg equilibrium (p>0.4). Minor allelef requenciesf or rs2097603, rs4633, rs4680 andr s174699 were 0.48 (G allele),0.47 (C allele),0.49 (G allele) and0.068 (C allele),respectively.Ofnote,the 324G allele (whichispresumed to be the wild-typeallele of rs4680)had alower frequencythan the 324A allele, which is alsoobservedinother studies(Table2). Linkage disequilibrium (D') andsquaredcorrelation coefficients between each of the genotypedvariants areshown in Table3.The SNPpair rs4680 (324G>A) andrs4633 (36T>C)w as in almost completeLD, with aD'of0.96 andasquaredcorrelation (r 2 )of 0.89. No strong LD wasobservedfor the otherSNP pairs.
Haplotypeassociations in the general population
Genotype data for all four polymorphismsw as obtainedf rom 401individuals (mean age 50.6 ±13.3 years), fromwhich 41.0% wasmale(n=164). Meanfasting tHcywas 10.4 (95% CI 10.0 to 10.8) µ M, serumcreatininwas 74.3 (95% CI 72.7 to 75.9) µ M, vitamin B12 was2 21 (95% CI 208 to 234) pM and folate was 13.1 (95% CI 12.3 to 13.9) nM. tHcywas correlated with plasma folate, red blood cell folate and vitamin B12 (Spearmann ρ values were -0.21, -0.24a nd -0.31, respectively,w ith p<0.01a ta two-tailedlevel).
Thehaplotypefrequencies andtheirrelative effects on tHcy are presented in Table4.Byomittingthe haplotypes withafrequency of less than twopercent, 95%ofthe haplotypes wascovered. The omnibusa ssociation test using all haplotypes for crudef asting tHcy showedab ordelines ignificant effect (p=0.05). Haplotype specificanalysis, i.e. analysisofthe effectofthe haplotype relative to themost commonhaplotype, showedthat theeffect wasmainly due to theG-C-G-T haplotype that wasstatisticallysignificant associated withl ow tHcyl evels (-13.3%[ 95% CI -23.6 to -3.1], p=0.01).A djustmentf or age,s ex,s erum creatinine, MTHFR 677C>T polymorphism and plasma folate didnot change this point estimate (notshown). Theomnibus haplotype test wasnolonger significant when the analysis wasconducted conditional on rs4680 or on rs4633 (p=0.28 and p=0.26, respectively).This meansthat the haplotype analysis did notreveal major additional effects besides that observedf or thes ingle-loci. Indeed,a ni ncrease of 10.4% (95% CI 0.01 to 0.21, p=0.03) and 8.8% (95% CI -0.00 to 0.18, p=0.06) in tHcywas observedfor COMT 324AAand 324GA(rs 4680) individuals, respectively,when compared with324GGsubjects ( Table 5 ).None of thegenotypes wasassociatedwith folate, red blood cell folate or vitamin B12 levels (notshown). Moreover, thefact that adjustment for folate status (an important determinant of tHcy)did not influence theassociation between the COMT haplotype and tHcysuggests that theobserved genotype-phenotype association is notconfounded by differences in vitamin status.
Furthermore, by comparing amodel in whichthe effects of the threehaplotypes containing allele Cand Gatthe second and third locus were constrained to be equal to amodel in whichall haplotype effectswere estimatedseparately, we found thatthe effects of the N-C-G-N haplotypes (whereNrepresentsone of the allelesobservedatthe first and fourthlocus) were notdifferent (p=0.18). This suggests thatthe haplotype background on which these variantsappearhad no major influenceontHcy.
The COMT 324G>A variant and recurrent venous thrombosis risk
Genotype data of theCOMT 324G>A(rs4680) polymorphism waso btained from 424 controls and 169, from which4 1% (n=174) and 51% (n=86) were male,respectively. Forthe controls, meanage and blood parameterswere similar as thoseindividuals included in the haplotype analysis. Forthe recurrent venous thrombosis cases (mean age 61.5 ±14.3 years)geometric mean (95% CI)tHcywas 12.6 (11.6to13.6) µ M, 83.1 (78.6 to 87.6) µ Mfor serum creatinin, 237 (207 to 267) pM for vitamin B12 and 13.7 (12.4 to 15.0) nM for folate.
The genotype frequenciesw ere 34.9%( n=59), 45.6% (n=77), 19.5% (n=33), and 27.6% (n=117), 47.6% (n=202), 24.8% (n=105) for AA, AG,GGgenotypesincases and controls, Ta ble3:Linkage disequilibrium coefficient(D')between SNPs across the COMT gene in controls. Abovethe diagonal theD'-values areshown and belowthe diagonal their correspondingsquared correlationcoefficients (initalics).
Variant
Rs number rs2097603 rs4633 rs4680 rs174699 responding withSNP 1, 2, 3and 4, respectively) as areference.
Ta ble4:Haplotype frequencies and relative changeintHcyin thegeneral population using theG-T-A-T haplotype (cor-
respectively.These correspond to minor (G)allele frequencies of 0.42 and 0.49 for cases and controls, respectively.Wefound that individuals with the 324AA genotype,corresponding with those having the highest tHcy, were at higher risk for recurrent venous thrombosis comparedwith 324GG subjects, although this estimation did not reach statistical significance( OR 1.61[ 95%CI 0.97 to 2.65], p = 0.06). The OR for individuals with the 324GA genotype was1.21 (95% CI 0.76 to 1.94, p=0.18). The other genetic variantswere notassociatedwith recurrent venous thrombosis risk (not shown)
Discussion
We screened forthe rs4680 variant as well as three other SNPs dispersed over the COMT gene (rs2097603,r s4633 and rs174699)and performed haplotype analysis in ordertoidentify whether aspecific haplotype wasrelated to tHcy. We showthat rs4680 wass ingularlya ssociatedw ith tHcyl evelsi naDutch population study,a nd wasr esponsible for the observedh aplotype effect.The small, butn on-significant, effect on tHcyt hat wasobservedfor variant rs4633(not shown) is likelytobeexplained by its high correlation with rs4680(Table2) (20, 30) . Interestingly, the 324AA genotype (rs4680) wasmore prevalent in venous thrombosis cases suggesting that this variant mayaffect recurrent venous thrombosis risk as well. The3 24G>A( rs4680) polymorphismh as been extensively studiedfor its effect at the molecularlevel,mostlybecauseofits potentialrole in schizophrenia susceptibility. Functionalstudies showedthat the COMT 324AA genotype is associated with decreased enzyme activity in vitro and in humanbrain extracts (22, 31) although the Va l-allele wasexpressed at aslightlylower level in humanbrain (23) . In the past, Goodmanetal. (19) showedthat the COMT 324G>Avariant affected tHcyincontrols, while Geiseletal. did not find such an effect in elderlysubjects (32) .Inaddition, it has beensuggestedthat other variantsmight explain the observedassociations (20) .Our resultsshowthat the 324AA ge-notype is significantly associatedw ith increased tHcyl evels, whichmay supportthe observation of higher expression of the Met-allele by Bray et al. (23) . The higher levels of tHcyassociated with the 324AA genotype mayexplain whythese subjects tend to have ahigherrisk for venous thrombosis.However,adisturbedmethylation by COMT in itself mayalso be involved,especially sincethe vascularsystem is constantlyexposed to circulating catecholamines and catecholestrogens. It has beenshown that catecholestrogens mayhavebeneficialeffectsonthe vascular systembyreducing fibrinogen and overallfibrinolysis potential(33), although negative effectshavealso been reported (16) . The measurement of plasma AdoMeta nd AdoHcyl evels, the ratio of whichisamarker of methylation capacity,and in-vitro methylation studies could provide additional evidencef or disturbedmethylation in subjectscarrying this variant.Itshould be noted that we includedpatients with ahistoryofvenous thrombosis, whichmay give an overestimation of the relativerisk. Additional studies arer equired to studyw hethert he COMT 324G>Apolymorphism is related to afirst thrombotic event.
One mayr aise the question whether it is plausible thatt he flux through the COMT enzyme is high enough to generate a relativelylarge difference in tHcy(about 10%) between subjects having the 324GG and 324AA genotype.S tudiesw ith Parkinson'sd iseasep atients whose tHcyl evelsr ose upon L-DOPA treatment (34) (35) (36) , indicatethat ahigherCOMT fluxisreflected in plasma tHcylevels. In addition, arecent genome-wide linkage scan performed by Souto et al.identified anothermethyltransferase, Nicotinamide N-methyltransferase(NNMT), as apossible major determinant of tHcy (37) . This shows that not onlymethyltransferases with ah igh flux-rate, likeg uanidinoacetate-and phosphatidylethanolamine methyltransferase (15) ,contribute to homocysteine synthesis, butalso methyltransferases with an apparently modest contribution to overallmethyltransferaseactivity.I nc onclusion, the 324AA genotype (rs4680) is associated with increased tHcyinthe generalpopulation. Subjects with the 324AA genotype also tend to have ahigherrisk for recurrent ve- 
